News

Roche and Flare Therapeutics are igniting a partnership worth more than $1.8 billion in biobucks with hopes of discovering new cancer drugs.
Epigenetic landscape modulates pioneer transcription factor binding Date: May 24, 2023 Source: St. Jude Children's Research Hospital Summary: Scientists studied how the epigenetic landscape ...
Transcription factor oligodeoxynucleotide (ODN) decoys are new research tools designed to enhance the study of gene regulation. The approach involves flooding the cells with enough double-stranded ...
Researchers resolved human transcription factor (TF) regulation. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 02 / 220209112141.htm. University of Helsinki.
The transcription factor FOXA1 has been one of the most coveted targets for a drug because it is implicated in the growth of breast and prostate cancers, according to Erb.
The ABA-induced NAC transcription factor MdNAC1 interacts with a bZIP-type transcription factor to promote anthocyanin synthesis in red-fleshed apples. Article Publication Date.